| Subset Analysis of Black Men Screened on the PLCO Prostate Cancer Screening Trial |
Curtiland Deville |
Johns Hopkins University |
PLCO |
Nov 2, 2015 |
PLCO-172 |
| Examining the association between the dietary inflammatory index (DII) and pancreatic cancer risk and potential mediation by type-2 Diabetes Mellitus (DM) |
Susan Steck |
University of South Carolina |
PLCO |
Oct 23, 2015 |
PLCO-171 |
| The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The Operations Behind a Herculean Task |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-155 |
| The importance of publishing on clinical trial operations |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-156 |
| The PLCO Cancer Screening Trial: Background, Goals, Organization, Operations, Results |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-157 |
| Building Successful Relationships in the PLCO Cancer Screening Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-158 |
| Managing Multi-Center Recruitment in the PLCO Cancer Screening Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-159 |
| Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-160 |
| Lessons in Medical Record Abstraction from the Prostate, Lung, Colorectal, and Ovarian (PLCO) National Screening Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-161 |
| Changes in and Impact of the Death Review Process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-162 |
| The PLCO Biorepository: Creating, Maintaining, and Administering a Unique Biospecimen Resource |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-163 |
| Comprehensive Quality Management (CQM) in the PLCO Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-164 |
| Data Processing and Analytic Support in the PLCO Cancer Screening Trial |
Pam Marcus |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-165 |
| PLCO: Evolution of an Epidemiologic Resource and Opportunities for Future Studies |
Black Amanda |
NCI |
PLCO |
Sep 16, 2015 |
PLCO-166 |
| Studying neighborhood characteristics and cancer risk in PLCO |
Qian Xiao |
NCI |
PLCO |
Sep 8, 2015 |
PLCO-154 |
| Prostate Cancer and PSA: Examining the role of mediation in the associations of individual characteristics with prostate specific antigen (PSA) and prostate cancer risk |
Sean Harrison |
University of Bristol |
PLCO |
Sep 8, 2015 |
PLCO-152 |
| Melanoma |
Gaston Liberman |
UTN FRBA |
PLCO |
Aug 25, 2015 |
PLCO-151 |
| DRE and prostate cancer detection in the PLCO cancer screening trial |
Jonathan Shoag |
NA |
PLCO |
Aug 24, 2015 |
PLCO-150 |
| Patterns of Care and Outcomes for Prostate Cancer in the United States |
Paul Nguyen |
Brigham and Women's Hospital |
PLCO |
Aug 17, 2015 |
PLCO-149 |
| History of lethal prostate cancer in the screening arm of PLCO |
Jonathan Shoag |
NA |
PLCO |
Aug 7, 2015 |
PLCO-147 |
